Osprey Medical (ASX:OSP) has launched a monthly educational podcast series designed for investors.
According to the company, the podcast series features five-to-seven minute discussions with its senior management, customers and other stakeholders, on topics such as acute kidney injury (AKI) reduction and kidney care protocol in US hospitals, relationships with Group Purchasing Organisations (GPOs), sales and marketing of its DyeVert system, and other ASX news flow.
The first podcast episode introduced investors to a DyeVert hospital customer who discusses how its use has contributed to a reduction in AKI incidents.
The second episode, released this week, features a discussion with Osprey Medical vice president of Clinical Affairs, Kimberly Knish, who speaks about the launch of its DyeMINISH registry.
Knish talks about the importance of real-world data in US healthcare and how the registry will benefit hospitals and healthcare administrators.
“We are delighted to launch an educational series focusing on short stakeholder discussions that provide a deeper insight into how we are meeting the needs of our customers and their patients," said Osprey Medical CEO Mike McCormick.
"The podcast series will also help investors better understand the US healthcare purchasing environment and the growing body of clinical data supporting Osprey’s dye-saving products.”